Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4666 |  NCEL NewcelX Ltd. - Ordinary Shares | 3.33 USD | +2.15% | -0.60% | -10.00% | -34.45% | 15.98 M USD | ||
| 4668 |  CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.17 USD | +0.46% | +13.61% | +55.00% | +46.62% | 15.61 M USD | ||
| 4671 |  TPST Tempest Therapeutics, Inc. - Common Stock | 1.03 USD | -0.96% | -5.50% | +13.19% | -56.90% | 15.25 M USD | ||
| 4673 |  BCDA BioCardia, Inc. - Common Stock | 1.02 USD | +0.99% | +8.51% | +13.33% | -12.07% | 15.44 M USD | ||
| 4677 |  AKTX Akari Therapeutics Plc - American Depositary Shares | 7.77 USD | 0.00% | -1.27% | -18.04% | +735.48% | 15.13 M USD | ||
| 4683 |  ICU SeaStar Medical Holding Corporation - Common Stock | 3.40 USD | +1.49% | +6.58% | -11.23% | +38.21% | 14.98 M USD | ||
| 4684 |  BIVI BioVie Inc. - Common stock | 1.86 USD | -4.62% | +47.62% | +36.76% | +47.62% | 14.03 M USD | ||
| 4693 |  PASG Passage Bio, Inc. - Common Stock | 4.39 USD | -1.13% | -1.13% | -8.92% | -50.34% | 14.13 M USD | ||
| 4700 |  LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 USD | +27.74% | +70.69% | +23.75% | -21.12% | 17.84 M USD | ||
| 4701 |  PHIO Phio Pharmaceuticals Corp. - Common Stock | 1.17 USD | -0.85% | +9.35% | +10.38% | -1.68% | 13.59 M USD | ||
| 4714 |  GTBP GT Biopharma, Inc. - Common Stock | 0.29 USD | 0.00% | 0.00% | -12.12% | -73.87% | 13.08 M USD | ||
| 4721 |  INAB IN8bio, Inc. - Common Stock | 1.29 USD | +0.78% | +21.70% | +4.88% | -22.75% | 12.72 M USD | ||
| 4725 |  DARE Dare Bioscience, Inc. - Common Stock | 0.81 USD | -1.22% | -8.99% | -36.72% | -50.91% | 12.38 M USD | ||
| 4727 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.37 USD | -2.63% | -19.57% | -40.32% | -67.83% | 12.05 M USD | ||
| 4729 |  PDSB PDS Biotechnology Corporation - Common Stock | 0.21 USD | -4.55% | -4.55% | -69.57% | -83.20% | 11.75 M USD | ||
| 4731 |  BLRX BioLineRx Ltd - American Depositary Shares | 2.89 USD | +2.85% | +1.05% | +1.76% | +2.85% | 12.58 M USD | ||
| 4733 |  GDTC CytoMed Therapeutics Limited - Ordinary Shares | 0.98 USD | -4.85% | +3.16% | +3.16% | -47.59% | 11.59 M USD | ||
| 4735 |  SNTI Senti Biosciences, Inc. - Common Stock | 0.35 USD | -10.26% | -16.67% | -12.50% | -63.16% | 10.90 M USD | ||
| 4745 |  KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.65 USD | -0.38% | +3.11% | +6.00% | +26.19% | 11.72 M USD | ||
| 4750 |  MBRX Moleculin Biotech, Inc. - Common Stock | 0.58 USD | -1.69% | -3.33% | -72.90% | -81.59% | 11.30 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |